CENTOGENE and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE $30 Million Investment

Joint Venture (JV) combines CENTOGENE's global leadership in multiomics with local insight of Lifera, a biopharmaceutical company wholly-owned by the Public Investment Fund (PIF) based in Riyadh

JV focuses on providing state-of-the-art multiomic…

7 Min
More

Max Delbrück Center has developed new technology to study virus infections

A new tool can identify cells that are actively responding to a SARS-CoV-2 infection. As reported in "Science Advances" by the Gargiulo lab, it can be used to screen for effective COVID-19 therapies and can be tailored to study other viruses as well.

3 Min
More

OMEICOS Therapeutics Receives 2.5 million Euros in Grant Funding Supporting OMT-28’s Development in Mitochondrial Diseases Through a Phase 2a Clinical Study

OMEICOS, a biopharmaceutical company developing first-in-class small molecule therapeutics based on the profound understanding of omega-3 fatty acid metabolism and physiology, announced today that the Company has received a significant grant by the…

2 Min
More

Max Delbrück Center is studying herpes encephalitis with mini-brains

The herpes simplex virus-1 can sometimes cause a dangerous brain infection. Combining an anti-inflammatory and an antiviral could help in these cases, report scientists with the Rajewsky and Landthaler labs and the Organoid Platform at the Max…

3 Min
More

Max Delbrück Center has developed a new tool to study complex genome interactions

Genome Architecture Mapping captures complex, multi-way interactions in the genome. This is different than the workhorse technique of 3D genomics, which sees mostly two-way contacts, finds a new study by a team led by Ana Pombo from the Max Delbrück…

3 Min
More

In portrait | HYBRICK – Modern laboratory and production space for the life science industry

Berlin-Brandenburg is one of the leading international life science locations. Here and throughout Germany, the healthcare industry is growing steadily. Suitable areas for research and development as well as production will therefore be needed more…

4 Min
More

REACT DX Registry Highlights Relevance of Atrial High-Rate Episode Remote Monitoring in ICD Patients

In combination with BIOTRONIK Home Monitoring® the DX ICD system is an effective and convenient way to detect AHRE and monitor atrial fibrillation events and burden

3 Min
More

Researchers from the Max Delbrück Center and the DZHK are exploring how the effects of a mutated gene that causes severe hypertension but also protects the kidneys from being damaged can be used therapeutically

A mutation that causes severe hypertension also protects the kidneys from being damaged, reports a team led by Enno Klußmann of the Max Delbrück Center and the DZHK in “Kidney International”. The researchers are now exploring how the effects of the…

3 Min
More

Clinical trial run by Charité and the Max Delbrück Center has been awarded a grant of several million euros to test a new immunotherapy approach

While CAR-T cells have proven successful in treating certain types of leukemia and lymphoma, these immunotherapies can become even more effective. A clinical trial run by Charité and the Max Delbrück Center has been awarded a grant of several million…

2 Min
More

Max Delbrück Center has investigated how the sensory cells of the vagus nerve react to mechanical stimuli in the esophagus in the process of swallowing

Sensory cells in the vagus nerve can detect and locate food in the esophagus. Their signals help transport the food onward to the stomach. Signal failure leads to swallowing disorders, say a team led by Carmen Birchmeier at the Max Delbrück Center.…

2 Min
More
Show more items